Purinethol
Purinethol

0.7
For patients managing oncology conditions, this generic medicine slows cellular division processes to address rapid cell growth in chronic conditions.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Mercaptopurine
Reference Brand
Mercaptopurine
Product Origin
Generic Alternative
Reference Manufacturer
GlaxoSmithKline
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Purine Antimetabolite
Pharmacological Class
Antineoplastic Agent
Clinical Indications
Manufacturer Description
Utilized to manage rapid lymphatic division to alleviate leukemic cells and support therapeutic remission.
Mechanism of Action
Competes with natural purines to incorporate into cell DNA and RNA, arresting molecular replication pathways.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Previous resistance to mercaptopurine, Pregnancy
Severe Adverse Events
Severe leukopenia — requires immediate medical attention, Severe hepatotoxicity — requires immediate medical attention
Common Side Effects
Nausea, Vomiting, Anorexia
Uncommon Side Effects
Myelosuppression, Skin pigmentation, Transient transaminase elevation
Drug Interactions
Allopurinol, Warfarin, Bactrim
Pregnancy Safety Warnings
TGA Category D: High risk of fetal toxicity. Strictly contraindicated. Breastfeeding: Contraindicated.
Age Restrictions
Approved for pediatric and adult populations.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Purinethol is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to purchase Obesity Treatment - Orlistat Fat Blocker Weight Loss